Control system for insertion devices at the advanced photon source

Eighteen insertion devices (IDs) are installed at the Advanced Photon Source (APS), and three more are scheduled for installation by the end of this year. A distributed control system for insertion devices at the APS storage ring was created with the Experimental Physics and Industrial Control System (EPICS). The basic components of this system are operator interfaces (OPIs), input output controllers (IOCs), and a local area network that allows the OPI and IOC to communicate. The IOC operates under the VxWorks OS with an EPICS database and a sequencer. The sequencer runs an ID control program written in State Notation Language. The OPI is built with the EPICS tool MEDM and provides display screens with input and output fields and buttons for gap control of the IDs. Global commands like ``open all IDs`` are C-shell scripts invoked from the display menu. The algorithms for control and protection of the ID and ID vacuum chamber and the accuracy of gap control are discussed

Buttons, Handles, and Keys: Advances in Continuous-Control Keyboard Instruments

This is the peer reviewed version of the following article: Buttons, Handles, and Keys: Advances in Continuous-Control Keyboard Instruments, which has been published in final form at http://dx.doi.org/10.1162/COMJ_a_00297. This article may be used for non-commercial purposes in accordance with MIT Press Journal's Terms and Conditions for Self-Archiving. © 2015, MIT Press Journal

Identification of FOXP1 Deletions in Three Unrelated Patients with Mental Retardation and Significant Speech and Language Deficits

Mental retardation affects 2-3% of the population and shows a high heritability. Neurodevelopmental disorders that include pronounced impairment in language and speech skills occur less frequently. For most cases, the molecular basis of mental retardation with or without speech and language disorder is unknown due to the heterogeneity of underlying genetic factors. We have used molecular karyotyping on 1523 patients with mental retardation to detect copy number variations (CNVs) including deletions or duplications. These studies revealed three heterozygous overlapping deletions solely affecting the forkhead box P1 (FOXP1) gene. All three patients had moderate mental retardation and significant language and speech deficits. Since our results are consistent with a de novo occurrence of these deletions, we considered them as causal although we detected a single large deletion including FOXP1 and additional genes in 4104 ancestrally matched controls. These findings are of interest with regard to the structural and functional relationship between FOXP1 and FOXP2. Mutations in FOXP2 have been previously related to monogenic cases of developmental verbal dyspraxia. Both FOXP1 and FOXP2 are expressed in songbird and human brain regions that are important for the developmental processes that culminate in speech and language. ©2010 Wiley-Liss, Inc

Psoriasin (S100A7) expression is altered during skin tumorigenesis

BACKGROUND: Psoriasin (S100A7) expression has previously been associated with psoriasiform hyperplasia as well as with tumor progression in breast cancer. Its expression profile for different stages of skin lesions is unknown. The aim of this study was to determine the relationship between psoriasin (S100A7) and tumor progression in skin. METHODS: Psoriasin was assessed by immunohistochemistry and levels of expression determined by semi-quantitative scoring in skin biopsies from 50 patients. The cohort included normal skin, actinic keratosis, squamous carcinoma in-situ, invasive squamous cell carcinoma, and basal cell carcinoma. RESULTS: In normal skin, psoriasin was rarely detected in epidermis but was expressed in underlying adnexae. In abnormal epidermis psoriasin was frequently expressed in abnormal keratinocytes in actinic keratosis, in-situ and invasive squamous cell carcinoma, but was rarely observed in the basal epidermal layer or in superficial or invasive basal cell carcinoma. The highest levels of expression were seen within squamous carcinoma in-situ. Significantly reduced levels of expression were observed in both unmatched (p = 0.0001) and matched (p < 0.004) invasive squamous cell carcinoma. Psoriasin expression within abnormal squamous lesions correlated with mitotic count (r = 0.54, p = 0.0036), however no significant relation was found with the intensity of dermal inflammatory cell infiltrates assessed within each pathology. CONCLUSION: These results suggest that altered psoriasin expression occurs in abnormal epidermis and that downregulation may be related to the onset of invasion in squamous cell carcinoma in skin